Back

Poolbeg Pharma says POLB 001 trial will proceed after safety review

Verifying
  • Poolbeg Pharma will continue the POLB 001 TOPICAL clinical trial as planned.
  • The interim safety review recommended no changes to the study protocol.
  • The trial is testing POLB 001 as a preventative treatment.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.